JPRN-jRCT1080222541未知Unknown
Zacras Combination Tablets LD & HD specified drug-use survey Long-term use survey
TAKEDA PHARMACEUTICAL COMPANY LTD.0 个研究点目标入组 1,090 人开始时间: 2014年6月25日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 发起方
- 入组人数
- 1,090
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •Hypertensive patients
排除标准
- •Hypertensive patients who meet any of the following conditions, [1] to [3], are excluded from the survey:
- •[1] Patients with a history of hypersensitivity to any of the ingredients of Zacras Combination Tablets or other dihydropyridine drugs
- •[2] Patients who are pregnant or having possibilities of being pregnant
- •[3] Diabetic patients taking aliskiren fumarate (excluding those with markedly poor blood pressure control even after other antihypertensive treatment)
研究者
相似试验
未知
Unknown
ECARD Combination Tablets LD&HD special drug use surveillance: Long-term use (12 months)HypertensionJPRN-jRCT1080222313TAKEDA PHARMACEUTICAL COMPANY LTD.3,000
未知
Unknown
nisia Combination Tablets LD, HD Special Drug Use Surveillance Hypertension: Long-Term UseHypertensionJPRN-jRCT1080222340TAKEDA PHARMACEUTICAL COMPANY LTD.3,000
尚未招募
不适用
Special drug use survey of DARZQURO Combination Subcutaneous Injection (Multiple Myeloma)Multiple MyelomaJPRN-UMIN000044074Janssen Pharmaceutical K.K.200
未知
Unknown
Sonias Combination Tablets LD special drug use surveillance Survey on Type 2 diabetes mellitus: Insufficient treatment response to PioglitazoneType 2 diabetes mellitusJPRN-jRCT1080222395TAKEDA PHARMACEUTICAL COMPANY LTD.210
未知
Unknown
Azilva Tablets special drug use surveillance Hypertension complicated by diabetesHypertensionJPRN-jRCT1080222416TAKEDA PHARMACEUTICAL COMPANY LTD.300